Authors:
and
Karina Kohutics
https://orcid.org/0009-0006-5929-5124
Karina Kohutics
ELTE Eötvös Loránd Tudományegyetem, Pszichológiai Intézet, Budapest , Magyarország
Search for other papers by Karina Kohutics in
Current site
Google Scholar
PubMed
Search for other papers by Karina Kohutics in
Current site
Google Scholar
PubMed
Adrien Rigó
rigo.adrien@ppk.elte.hu
https://orcid.org/0000-0003-2940-2110
Adrien Rigó
ELTE Eötvös Loránd Tudományegyetem, Pszichológiai Intézet, Budapest , Magyarország
Search for other papers by Adrien Rigó in
Current site
Google Scholar
PubMed
Search for other papers by Adrien Rigó in
Current site
Google Scholar
PubMed
A pikkelysömör a leggyakoribb autoinflammatorikus bőrbetegség. Krónikus bőrbetegség lévén a tünetek megfelelő menedzselése és a tünetmentes állapot elérése az elsődleges feladat, ami a modern kezelésekkel ma már megvalósulhat. A betegséggel együtt járó kihívások azonban jelentős életminőségromlással is társulhatnak. A tünetek miatt gyakran sérül a testkép, az énkép, a társas kapcsolatok és a mentális egészség, így az érintetteknek szükségük lehet a komplex ellátásra és a pszichológiai támogatásra is. Jelen tanulmány célja a betegség biopszichoszociális szempontú bemutatása, külön figyelmet szentelve a stressz potenciális szerepének, az életmódbeli faktoroknak és a lehetséges egészségpszichológiai intervencióknak.
Psoriasis is the most common autoinflammatory skin disease. As a chronic skin condition, the primary concern is the proper management of symptoms and achieving asymptomatic status, which can now be achieved with modern treatments. However, the symptoms and challenges associated with the disease can also be associated with a significant reduction in quality of life. Symptoms can often affect body image, self-image, social relationships, and mental health, so people may need complex care and psychological support. The aim of this study is to present the disease from a biopsychosocial perspective, with particular attention to the potential role of stress, lifestyle factors, and possible health psychological interventions.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
Aktaş Karabay, E., Fişek İzci, N., & Aksoy, B. (2020). Psoriasis affects self‐perception of stress negatively: A prospective, case‐ control study. Dermatologic Therapy, 33(6), Article e13864.
-
Almeida, V., Taveira, S., Teixeira, M., Almeida, I., Rocha, J., & Teixeira, A. (2017). Emotion regulation in patients with psoriasis: Correlates of disability, clinical dimensions, and psychopathology symptoms. International Journal of Beha-vioral Medicine, 24(4), 563–570.
-
Amatya, B., Wennersten, G., & Nordlind, K. (2008). Patients’ perspective of pruritus in chronic plaque psoriasis: A questionnaire-based study. Journal of the European Academy of Der-matology and Venereology, 22(7), 822–826.
-
Ammar-Khodja, A., Benkaidali, I., Bouadjar, B., Serradj, A., Titi, A., Benchikhi, H., Amal, S., Hassam, B., Sekkat, A., Mernissi, F. Z., Mokhtar, I., Dahoui, R., Denguezli, M., Doss, N., & Turki, H. (2015). EPIMAG: International cross-sectional epidemio-logical psoriasis study in the Maghreb. Dermatology, 231(2), 134–144.
-
Armstrong, A. W., Armstrong, E. J., Fuller, E. N., Sockolov, M. E., & Voyles, S. V. (2011). Smoking and pathogenesis of psoriasis: A review of oxidative, inflammatory and genetic mechanisms: Smoking and pathogenesis of psoriasis. British Journal of Dermatology, 165(6), 1162–1168.
-
Armstrong, A. W., Schupp, C., Wu, J., & Bebo, B. (2012). Quality of life and work productivity impairment among psoriasis patients: Findings from the National Psoriasis Foundation survey data 2003–2011. PLOS ONE, 7(12), Article e52935.
-
Augustin, M. (2013). Cumulative life course impairment: Identifying patients at risk. In: M. D. Linder & A. B. Kimball (Eds.), Current Problems in Dermatology (vol. 44, pp. 74–81). Karger.
-
Augustin, M., Reich, K., Blome, C., Schäfer, I., Laass, A., & Radtke, M. A. (2010). Nail psoriasis in Germany: Epidemiology and burden of disease: Nail psoriasis in Germany. British Journal of Dermatology, 163(3), 580–585.
-
Balogh, O., Brodszky, V., Gulácsi, L., Herédi, E., Herszényi, K., Jókai, H., Kárpáti, S., Baji, P., Remenyik, É., Szegedi, A., & Holló, P. (2014). Cost-of-illness in patients with moderate to severe psoriasis: A cross-sectional survey in Hungarian dermatological centres. The European Journal of Health Economics, 15(S1), 101–109.
-
Barlow, J., Wright, C., Sheasby, J., Turner, A., & Hainsworth, J. (2002). Self-management approaches for people with chronic conditions: A review. Patient Education and Counseling, 48(2), 177–187.
-
Basińska, M. A., & Drozdowska, M. (2013). Emotional intelligence as an indicator of satisfaction with life of patients with psoriasis. Advances in Dermatology and Allergology, 6, 365–372.
-
Bata Z. (2005). A pikkelysömör pathomechanizmusáról. Doktori Értekezés. Szeged.
-
Bata-Csörgő, Zs. & Gyulai, R. (2018). The pathogenesis of psoriasis. Bőrgyógyászati és Venerológiai Szemle, 94, 178–181.
-
Boehncke, W. H., Schön, M. P. (2015). Psoriasis. Lancet, 386, 983–994.
-
Brihan, I., Ianoși, S., Boda, D., Hălmăjan, A., Zdrîncă, M., & Fekete, L. (2020). Implications of self-esteem in the quality of life in patients with psoriasis. Experimental and Therapeutic Medi cine, 20(6), article number: 202.
-
Ciuluvica, C., Amerio, P., & Fulcheri, M. (2014). Emotion regulation strategies and quality of life in dermatologic patients. Procedia–Social and Behavioral Sciences, 127, 661–665.
-
Ciuluvica, C., Fulcheri, M., & Amerio, P. (2019). Expressive suppression and negative affect, pathways of emotional dys-regulation in psoriasis patients. Frontiers in Psychology, 10, 1907.
-
D’Erme, A. M., Zanieri, F., Campolmi, E., Santosuosso, U., Betti, S., Agnoletti, A. F., Cossidente, A., & Lotti, T. (2014). Therapeutic implications of adding the psychotropic drug escitalopram in the treatment of patients suffering from moderate-severe psoriasis and psychiatric comorbidity: A retrospective study: Escitalopram and psoriasis. Journal of the European Academy of Dermatology and Venereology, 28(2), 246–249.
-
Dhir, V., & Aggarwal, A. (2013). Psoriatic arthritis: A critical review. Clinical Reviews in Allergy & Immunology, 44(2), 141–148.
-
DiMatteo, M. R., Haskard-Zolnierek, K. B., & Martin, L. R. (2012). Improving patient adherence: A three-factor model to guide practice. Health Psychology Review, 6(1), 74–91.
-
Dobos, A. B. (2017). A biológiai gyógyszerek költséghatékonysá- gának vizsgálata a pikkelysömör betegségben. Szakdolgozat. Buda pesti Corvinus Egyetem Közgazdaságtudományi Kar Egészségügyi Közgazdaságtan Tanszék
-
Dodoo-Schittko, F. (2018). Psoriasis: The significance of psychological stress. British Journal of Dermatology, 178(5), 1002.
-
Dubertret, L., Mrowietz, U., Ranki, A., Van De Kerkhof, P. C. M., Chimenti, S., Lotti, T., Schäfer, G., & EUROPSO patient survey. (2006). European patient perspectives on the impact of psoriasis: The EUROPSO patient membership survey: EUROPSO patient quality of life survey. British Journal of Dermatology, 155(4), 729–736.
-
Eghlileb, A. M., Davies, E. E. G., & Finlay, A. Y. (2007). Psoriasis has a major secondary impact on the lives of family members and partners. British Journal of Dermatology, 156(6), 1245–1250.
-
Emre, S., Metin, A., Demirseren, D. D., Kilic, S., Isikoglu, S., & Erel, O. (2013). The relationship between oxidative stress, smoking and the clinical severity of psoriasis. Journal of the European Academy of Dermatology and Venereology, 27(3), e370–e375.
-
Eskin, M., Şavk, E., Uslu, M., & Küçükaydoğan, N. (2014). Social problem-solving, perceived stress, negative life events, depression and life satisfaction in psoriasis. Journal of the European Academy of Dermatology and Venereology, 28(11), 1553–1559.
-
Esposito, M., Saraceno, R., Giunta, A., Maccarone, M., & Chimenti, S. (2006). An Italian study on psoriasis and depression. Dermatology, 212(2), 123–127.
-
Farkas, Á., & Kemény, L. (2010). Psoriasis and alcohol: Is cutaneous ethanol one of the missing links?: Possible link between psoriasis and alcohol misuse. British Journal of Dermatology, 162(4), 711–716.
-
Feldman, S., Behnam, S. M., Behnam, S. E., & Koo, J. Y. M. (2005). Involving the patient: Impact of inflammatory skin disease and patient-focused care. Journal of the American Academy of Dermatology, 53(1), S78–S85.
-
Fortune, D. G., Richards, H. L., Kirby, B., McElhone, K., Markham, T., Rogers, S., Main, C. J., & Griffiths, C. E. M. (2003). Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Archives of Dermatology, 139(6), 752–756.
-
Fortune, D. G., Richards, H. L., Main, C. J., & Griffiths, C. E. M. (2002). Patients’ strategies for coping with psoriasis: Coping with psoriasis. Clinical and Experimental Dermatology, 27(3), 177–184.
-
Frankel, H. C., Han, J., Li, T., & Qureshi, A. A. (2012). The association between physical activity and the risk of incident psoriasis. Archives of Dermatology, 148(8), 918–924.
-
Gáspár, K., Nagy, M., Herédi, E., Nagy, G., & Szegedi, A. (2013). A psoriasisos betegek kezelésében megfigyelhető változások az elmúlt évtizedben a Debreceni Egyetem Orvos-és Egészségtudományi Centrum Bőrgyógyászati Klinikáján és a területi járóbeteg szakrendeléseken. Bőrgyógyászati és Venerológiai Szemle, 89(4), 99–104.
-
Gisondi, P., & Girolomoni, G. (2007). Biologic therapies in psoriasis: A new therapeutic approach. Autoimmunity Reviews, 6(8), 515–519.
-
Gisondi, P., & Girolomoni, G. (2009). Psoriasis and Atherothrombotic Diseases: Disease-Specific and Non–Disease-Specific Risk Factors. Seminars in Thrombosis and Hemostasis, 35(3), 313–324.
-
Goff, K. L., Karimkhani, C., Boyers, L. N., Weinstock, M. A., Lott, J. P., Hay, R. J., Coffeng, L. E., Norton, S. A., Naldi, L., Dunnick, C., Armstrong, A. W., & Dellavalle, R. P. (2015). The global burden of psoriatic skin disease. British Journal of Dermatology, 172(6), 1665–1668.
-
Griffiths, C. E. M., & Richards, H. L. (2001). Psychological influences in psoriasis: Psychological influences in psoriasis. Clinical and Experimental Dermatology, 26(4), 338–342.
-
Griffiths, C. E., & Barker, J. N. (2007). Pathogenesis and clinical features of psoriasis. Lancet, 370, 263–271.
-
Gupta, M. A., Schork, N. J., Gupta, A. K., Kirkby, S., & Ellis, C. N. (1993). Suicidal ideation in psoriasis. International Journal of Dermatology, 32(3), 188–190.
-
Gyulai, R. (2017). A pikkelysömör klinikai, biokémiai, immunológiai és genetikai jellegzetességeinek vizsgálata. Akadémiai nagydoktori értekezés, PTE
-
Gyulai, R., & Kemény, L. (2006). The immunology of psoriasis: From basic research to the bedside. Orvosi Hetilap, 147(46), 2213–2220.
-
Henseler, T., & Christophers, E. (1985). Psoriasis of early and late onset: Characterization of two types of psoriasis vulgaris. Journal of the American Academy of Dermatology, 13(3), 450–456.
-
Herron, M. D., Hinckley, M., Hoffman, M. S., Papenfuss, J., BHansen, C. B., Callis, K. P., & Krueger, G. G. (2005). Impact of obesity and smoking on psoriasis presentation and management. Archives of Dermatology, 141(12), 1527–1534.
-
Hrehorów, E., Salomon, J., Matusiak, L., Reich, A., & Szepietowski, J. (2012). Patients with psoriasis feel stigmatized. Acta Dermato Venereologica, 92(1), 67–72.
-
Janowski, K., Steuden, S., & Bogaczewicz, J. (2014). Clinical and psychological characteristics of patients with psoriasis reporting various frequencies of pruritus. International Journal of Dermatology, 53(7), 820–829.
-
Janowski, K., Steuden, S., Pietrzak, A., Krasowska, D., Kaczmarek, Ł., Gradus, I., & Chodorowska, G. (2012). Social support and adaptation to the disease in men and women with psoriasis. Archives of Dermatological Research, 304(6), 421–432.
-
Jensen, P., & Skov, L. (2016). Psoriasis and Obesity. Dermatology 232(6), 633–639.
-
Jensen, P., Ahlehoff, O., Egeberg, A., Gislason, G., Hansen, P., & Skov, L. (2016). Psoriasis and new-onset depression: A Danish nationwide cohort study. Acta Dermato Venereologica, 96(1), 39–42.
-
Kemény, L., Szabó, K., Széll, M., & Bata-Csörgő, Z. (2014). Der- matoimmunológiai kutatások. In: Élő természettudományok (Köt. 4, pp. 239–255). Szegedi Egyetemi Kiadó. http://acta.bibl.u-szeged.hu/id/eprint/40147
-
Khoury, L. R., Danielsen, P. L., & Skiveren, J. (2014). Body image altered by psoriasis. A study based on individual interviews and a model for body image. Journal of Dermatological Treatment, 25(1), 2–7.
-
Kim, G. E., Seidler, E., & Kimball, A. B. (2015). Effect of age at diagnosis on chronic quality of life and long-term outcomes of individuals with psoriasis. Pediatric Dermatology, 32(5), 656–662.
-
Kimball, A. B., Jacobson, C., Weiss, S., Vreeland, M. G., & Wu, Y. (2005). The psychosocial burden of psoriasis. American Journal of Clinical Dermatology, 6(6), 383–392.
-
Kimball, A., Gieler, U., Linder, D., Sampogna, F., Warren, R., & Augustin, M. (2010). Psoriasis: Is the impairment to a patient’s life cumulative? Cumulative life course impairment in psoriasis. Journal of the European Academy of Dermatology and Venereology, 24, 989–1004.
-
Kirby, B., Richards, H. L., Mason, D. L., Fortune, D. G., Main, C. J., & Griffiths, C. E. M. (2007). Alcohol consumption and psychological distress in patients with psoriasis. British Jour-nal of Dermatology, 158(1), 138–140.
-
Kohlné Papp, I., & Perczel-Forintos, D. (2020). Hogyan fogyjunk tudatosan? – Munkafüzet kognitív viselkedésterápiás testsúly- csökkentő programhoz. Oriold és Társai Kiadó
-
Koo, J., Lee, E., Lee, C. S., & Lebwohl, M. (2004). Psoriasis. Journal of the American Academy of Dermatology, 50(4), 613–622.
-
Korkoliakou, P., Efstathiou, V., Giannopoulou, I., Christodoulou, C., Kouris, A., Rigopoulos, D., & Douzenis, A. (2017). Psycho-pathology and alexithymia in patients with psoriasis. Anais Brasileiros de Dermatologia, 92(4), 510–515.
-
Kouris, A., Platsidaki, E., Kouskoukis, C., & Christodoulou, C. (2017). Psychological parameters of psoriasis. Psychiatriki, 28(1), 54–59.
-
Kowalewska, B., Cybulski, M., Jankowiak, B., & Krajewska-Kułak, E. (2020). Acceptance of illness, satisfaction with life, sense of stigmatization, and quality of life among people with psoriasis: A cross-sectional study. Dermatology and Therapy, 10(3), 413–430.
-
Krishnadas, R., Nicol, A., Sassarini, J., Puri, N., Burden, A. D., Leman, J., Combet, E., Pimlott, S., Hadley, D., McInnes, I. B., & Cavanagh, J. (2016). Circulating tumour necrosis factor is highly correlated with brainstem serotonin transporter availability in humans. Brain, Behavior, and Immunity, 51, 29–38.
-
Lahousen, T., Kupfer, J., Gieler, U., Hofer, A., Linder, M., & Schut, C. (2016). Differences Between Psoriasis Patients and Skin-healthy Controls Concerning Appraisal of Touching, Shame and Disgust. Acta Dermato Venereologica, Suppl 217, 78–82.
-
Langeland, E., Robinson, H. S., Moum, T., Larsen, M. H., Krogstad, A.-L., & Wahl, A. K. (2013). Promoting sense of coherence: Salutogenesis among people with psoriasis undergoing patient education in climate therapy. BMC Psychology, 1(1), Article 11.
-
Lim, D. S., Bewley, A., & Oon, H. H. (2018). Psychological profile of patients with psoriasis. Annals of the Academy of Medicine, Singapore, 47(12), 516–522. https://annals.edu.sg/pdf/47VolNo12Dec2018/MemberOnly/V47N12p516.pdf
-
Lønnberg, A. S., Skov, L., Skytthe, A., Kyvik, K. O., Pedersen, O. B., & Thomsen, S. F. (2016). Smoking and risk for psoriasis: a population-based twin study. International Journal of Der-matology, 55(2), e72–e78.
-
Madden, S. K., Flanagan, K. L., & Jones, G. (2020). How lifestyle factors and their associated pathogenetic mechanisms impact psoriasis. Clinical Nutrition, 39(4), 1026–1040.
-
Marson, J. W., Snyder, M. L., & Lebwohl, M. G. (2021). Newer Therapies in Psoriasis. Medical Clinics of North America, 105(4), 627–641.
-
Mattei, P. L., Corey, K. C., & Kimball, A. B. (2014). Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The correlation between disease severity and psychological burden in patients treated with biological therapies. Journal of the European Academy of Dermatology and Vene-reology, 28(3), 333–337.
-
Mrowietz, U., Kragballe, K., Reich, K., Spuls, P., Griffiths, C. E., Nast, A., Franke, J., Antoniou, C., Arenberger, P., Balieva, F., Bylaite, M., Correia, O., Daudén, E., Gisondi, P., Iversen, L., Kemény, L., Lahfa, M., Nijsten, T., Rantanen, T., Reich, A., Rosenbach, T., Segaert, S., Smith, C., Talme, T., Volc-Platzer, B., & Yawalkar, N. (2011). Definition of treatment goals for moderate to severe psoriasis: a European consensus. Archives of Dermatological Research, 303(1), 1–10.
-
Mrowietz, U., Steinz, K., & Gerdes, S. (2014). Psoriasis: To treat or to manage? Experimental Dermatology, 23(10), 705–709.
-
Mustafa, A. A., & Al-Hoqail, I. A. (2013). Biologic systemic therapy for moderate-to-severe psoriasis: A review. Journal of Taibah University Medical Sciences, 8(3), 142–150.
-
Naldi, L. (2016). Psoriasis and smoking: Links and risks. Targets and Therapy, 6, 65–71.
-
Naldi, L., Chatenoud, L., Linder, D., Belloni Fortina, A., Peserico, A., Virgili, A. R., Bruni, P. L., Ingordo, V., Scocco, G. L., Solaroli, C., Schena, D., Barba, A., Di Landro, A., Pezzarossa, E., Arcangeli, F., Gianni, C., Betti, R., Carli, P., Farris, A., & Vecchia, C. L. (2005). Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: Results from an Italian case–control study. Journal of Investigative Dermatology, 125(1), 61–67.
-
Nickoloff, B. J, Nestle, F. O. (2004). Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. Journal of Clinical Investigation, 113, 1664–1675.
-
Nograles, K. E., Zaba, L. C., Guttman-Yassky, E., Fuentes-Duculan, J., Suárez-Fariñas, M., Cardinale, I., Krueger, J. G. (2008). Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. British Journal of Dermatology, 159, 1092–1102.
-
Ogłodek, E., Augustyńska, B., Marek, L., Araszkiewicz, A., Placek, W., & Mós, D. (2009). Poczucie koherencji u chorujacych na łuszczyce. Polski Merkuriusz Lekarski, 27(159), 202–204.
-
Ograczyk, A., Miniszewska, J., Pietrzak, A., & Zalewska-Janowska, A. (2017). Sense of coherence as a protective factor in chronic urticaria. Advances in Dermatology and Allergology, 2, 168–173.
-
Panasiti, M. S., Ponsi, G., & Violani, C. (2020). Emotions, alexithymia, and emotion regulation in patients with psoriasis. Frontiers in Psychology, 11, Article 836.
-
Pancar, Y. E., Durmus, D., & Sarisoy, G. (2019). Perceived stress, life events, fatigue and temperament in patients with psoriasis. Journal of International Medical Research, 47(9), 4284–4291.
-
Pariser, D., Schenkel, B., Carter, C., Farahi, K., Brown, T. M., Ellis, C. N., & for the Psoriasis Patient Interview Study Group (2016). A multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis. Journal of Der matological Treatment, 27(1), 19–26.
-
Parisi, R., Symmons, D. P., Griffiths, C. E., Ashcroft, D. M., & Identification and Management of Psoriasis and Associated Comorbidity (IMPACT) project team (2013). Global epidemiology of psoriasis: a systematic review of incidence and prevalence. The Journal of Investigative Dermatology, 133(2), 377–385.
-
Parisi, R., Webb, R. T., Carr, M. J., Moriarty, K. J., Kleyn, C. E., Griffiths, C. E. M., & Ashcroft, D. M. (2017). Alcohol-related mortality in patients with psoriasis: A population-based cohort study. JAMA Dermatology, 153(12), 1256–1262.
-
Pereira, M. G., Brito, L., & Smith, T. (2012). Dyadic adjustment, family coping, body image, quality of life and psychological morbidity in patients with psoriasis and their partners. International Journal of Behavioral Medicine, 19(3), 260–269.
-
Petraškienė, R., Valiukevičienė, S., & Macijauskienė, J. (2016). Associations of the quality of life and psychoemotional state with sociodemographic factors in patients with psoriasis. Medicina, 52(4), 238–243.
-
Picardi, A., Mazzotti, E., Gaetano, P., Cattaruzza, M. S., Baliva, G., Melchi, C. F., Biondi, M., & Pasquini, P. (2005). Stress, social support, emotional regulation, and exacerbation of diffuse plaque psoriasis. Psychosomatics, 46(6), 556–564.
-
Pilling, J. (2018). Orvosi kommunikáció a gyakorlatban. Medicina Könyvkiadó.
-
Pócs, D., Hamvai, Cs., & Kelemen, O. (2017). Magatartás-változtatás az egészségügyben: a motivációs interjú. Orvosi Hetilap, 158(34), 1331–1337.
-
Pompili, M., Innamorati, M., Erbuto, D., & Costanzo, A. (2016). Psychiatric comorbidity and suicide risk in patients with psoriasis. European Psychiatry, 33(S1), S395–S396.
-
Ponsi, G., Monachesi, B., Panasiti, V., Aglioti, S. M., & Panasiti, M. S. (2019). Physiological and behavioral reactivity to social exclusion: A functional infrared thermal imaging study in patients with psoriasis. Journal of Neurophysiology, 121(1), 38–49.
-
Purebl Gy. (2018). Alacsony intenzitású pszichológiai intervenciók a mindennapi orvosi gyakorlatban. Oriold és Társai Kiadó
-
Rapalli, V. K., Waghule, T., Gorantla, S., Dubey, S. K., Saha, R. N., & Singhvi, G. (2020). Psoriasis: Pathological mechanisms, current pharmacological therapies, and emerging drug delivery systems. Drug Discovery Today, 25(12), 2212–2226.
-
Reich, A., Welz-Kubia, K., & Rams, Ł. (2014). Apprehension of the disease by patients suffering from psoriasis. Advances in Dermatology and Allergology, 5, 289–293.
-
Rencz F., Brodszky V., Péntek M., Balogh O., Remenyik É., Szegedi A., Holló P., Kárpáti S., Jókai H., Herszényi K., Herédi E., Szántó S., & Gulácsi L. (2014). Disease burden of psoriasis associated with psoriatic arthritis in Hungary. Orvosi Hetilap, 155(48), 1913–1921.
-
Ricardo, J. W., & Lipner, S. R. (2021). Nail psoriasis in older adults. Dermatologic Clinics, 39(2), 195–210.
-
Richards, H. L., Fortune, D. G., Main, C. J., & Griffiths, C. E. M. (2003). Stigmatization and psoriasis. British Journal of Der-matology, 149(1), 209–211.
-
Richer, V., Roubille, C., Fleming, P., Starnino, T., McCourt, C., McFarlane, A., Siu, S., Kraft, J., Lynde, C., Pope, J. E., Keeling, S., Dutz, J., Bessette, L., Gulliver, W. P., Haraoui, B., & Bissonnette, R. (2016). Psoriasis and smoking: A systematic literature review and meta-analysis with qualitative analysis of effect of smoking on psoriasis severity. Journal of Cutaneous Medicine and Surgery, 20(3), 221–227.
-
Rousset, L., & Halioua, B. (2018). Stress and psoriasis. International Journal of Dermatology, 57(10), 1165–1172.
-
Russo, P. A., Ilchef, R., & Cooper, A. J. (2004). Psychiatric morbidity in psoriasis: A review. Australasian Journal of Dermatology, 45(3), 155–161.
-
Safdari, R., Firoz, A., & Masoorian, H. (2017). Identifying training and informational components to develop a psoriasis self-management application. Medical Journal of the Islamic Republic of Iran, 31(1), 383–390.
-
Sampogna, F., Chren, M. M., Melchi, C. F., Pasquini, P., Tabolli, S., Abeni, D., & The Italian Multipurpose Psoriasis Research on Vital Experiences (Improve) Study Group. (2006). Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis: Quality of life in older patients with psoriasis. British Journal of Dermatology, 154(2), 325–331.
-
Sampogna, F., Tabolli, S., & Abeni, D. (2012). Living with psoriasis: Prevalence of shame, anger, worry, and problems in daily activities and social life. Acta Dermato Venereologica, 92(3), 299–303.
-
Setty, A. R., Curhan, G., & Choi, K. H. (2007). Obesity, Waist Circumference, Weight change, and the risk of psoriasis in women: Nurses’ Health Study II. Archives of Internal Medicine, 167(15), 1670.
-
Sizto, S., Bansback, N., Feldman, S. R., Willian, M. K., & Anis, A. H. (2009). Economic evaluation of systemic therapies for moderate to severe psoriasis. British Journal of Dermatology, 160(6), 1264–1272.
-
Smith, T. J., Wilson, M., Karl, J. P., Orr, J., Smith, C., Cooper, A., Heaton, K., Young, A. J., & Montain, S. J. (2018). Impact of sleep restriction on local immune response and skin barrier restoration with and without “multinutrient” nutrition intervention. Journal of Applied Physiology, 124(1), 190–200.
-
Stauder A., Balog P., Kovács M., & Susánszky É. (2016). A Williams ÉletKészségek® stresszkezelő és pszichoszociális készségfejlesztő program magyar adaptációja és 10 éves tapasztalatai. Mentálhigiéné és Pszichoszomatika, 17(2), 81–95.
-
Svanström, C., Lonne-Rahm, S.-B., & Nordlind, K. (2019). Psoriasis and alcohol. Targets and Therapy, 9, 75–79.
-
Tsoi, L. C., Spain, S. L., Knight, J., Ellinghaus, E., Stuart, P. E., Capon, F., Ding, J., Li, Y., Tejasvi, T., Gudjonsson, J. E., et al. (2012). Identification of fifteen new psoriasis susceptibility loci highlights the role of innate immunity. Nature Genetics, 44, 1341–1348.
-
van Beugen, S., van Middendorp, H., Ferwerda, M., Smit, J. V., Zeeuwen-Franssen, M. E. J., Kroft, E. B. M., de Jong, E. M. G. J., Donders, A. R. T., van de Kerkhof, P. C. M., & Evers, A. W. M. (2017). Predictors of perceived stigmatization in patients with psoriasis. British Journal of Dermatology, 176(3), 687–694.
-
Verhoeven, E. W. M., Kraaimaat, F. W., de Jong, E. M. G. J., Schalkwijk, J., van de Kerkhof, P. C. M., & Evers, A. W. M. (2009). Individual differences in the effect of daily stressors on psoriasis: A prospective study. British Journal of Dermatology, 161(2), 295–299.
-
Verhoeven, E. W. M., Kraaimaat, F. W., van de Kerkhof, P. C. M., van Weel, C., Duller, P., van der Valk, P. G. M., van den Hoogen, H. J. M., Bor, J. H. J., Schers, H. J., & Evers, A. W. M. (2007). Prevalence of physical symptoms of itch, pain and fatigue in patients with skin diseases in general practice. British Journal of Dermatology, 156(6), 1346–1349.
-
Weiss, S. C., Kimball, A. B., Liewehr, D. J., Blauvelt, A., Turner, M. L., & Emanuel, E. J. (2002). Quantifying the harmful effect of psoriasis on health-related quality of life. Journal of the American Academy of Dermatology, 47(4), 512–518.
-
Wikonkál, N. (2015). The effect of complete clearing of symptoms on quality of life in psoriatic patients. Bôrgyógyászati és Vene-ro lógiai Szemle, 91(6), 248–250.
-
Wojtyna, E., Łakuta, P., Marcinkiewicz, K., Bergler-Czop, B., & Brzezińska-Wcisło, L. (2017). Gender, body image and social support: Biopsychosocial determinants of depression among patients with psoriasis. Acta Dermato Venereologica, 97(1), 91–97.
-
World Health Organization (2016). Global report on psoriasis. World Health Organization. https://apps.who.int/iris/handle/10665/204417
-
Yang, H., & Zheng, J. (2020). Influence of stress on the development of psoriasis. Clinical and Experimental Dermatology, 45(3), 284–288.
Editorial Correspondence: Czeglédi, Edit
Institute of Behavioural Sciences
Semmelweis University
Nagyvárad tér 4.
H-1089 Budapest, Hungary
Phone: (36 1) 210 2930 ext. 56151 ---- Fax: (36 1) 210 2955
E-mail: mentalhigiene.pszichoszomatika@gmail.com
Indexing and Abstracting Services:
- PsychInfo
- SCOPUS
- CABELLS Journalytics
| 2023 | |
|---|---|
| Scopus | |
| CiteScore | 0.6 |
| CiteScore rank | Q4 (Psychiatry and Mental Health) |
| SNIP | 0.149 |
| Scimago | |
| SJR index | 0.141 |
| SJR Q rank | Q4 |
| Mentálhigiéné és Pszichoszomatika | |
|---|---|
| Publication Model | Online Only Hybrid |
| Submission Fee | none |
| Article Processing Charge | 900 EUR/article |
| Printed Color Illustrations | 40 EUR (or 10 000 HUF) + VAT / piece |
| Regional discounts on country of the funding agency | World Bank Lower-middle-income economies: 50% World Bank Low-income economies: 100% |
| Further Discounts | Editorial Board / Advisory Board members: 50% Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100% |
| Subscription fee 2025 | Online subsscription: 120 EUR / 132 USD |
| Subscription Information | Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content. |
| Purchase per Title | Individual articles are sold on the displayed price. |
| Mentálhigiéné és Pszichoszomatika | |
|---|---|
| Language | English Hungarian |
| Size | B5 |
| Year of Foundation |
2000 |
| Volumes per Year |
1 |
| Issues per Year |
4 |
| Founder | Végeken Egészséglélektani Alapítvány |
| Founder's Address |
H-1089 Budapest, Hungary Nagyvárad tér 4. |
| Publisher | Akadémiai Kiadó |
| Publisher's Address |
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245. |
| Responsible Publisher |
Chief Executive Officer, Akadémiai Kiadó |
| ISSN | 1419-8126 (Print) |
| ISSN | 1786-3759 (Online) |
Monthly Content Usage
| Abstract Views | Full Text Views | PDF Downloads | |
|---|---|---|---|
| Jul 2024 | 0 | 202 | 132 |
| Aug 2024 | 0 | 190 | 183 |
| Sep 2024 | 0 | 302 | 229 |
| Oct 2024 | 0 | 725 | 199 |
| Nov 2024 | 0 | 787 | 195 |
| Dec 2024 | 0 | 611 | 175 |
| Jan 2025 | 0 | 195 | 83 |
Authors:
, , , , , and
Authors:
, , , , , and
Authors:
, , , , , , , and
Copyright Akadémiai Kiadó AKJournals is the trademark of Akadémiai Kiadó's journal publishing business branch.
Powered by PubFactory